Long Term Adverse Effects
Recent clinical, regulatory, research and industry developments relating to this disease.
Management of post-acute covid-19 in primary care.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes5
- Coronavirus Infections1
- Long Term Adverse Effects1
- Pandemics1
- Pneumonia, Viral1
- Recovery of Function1
Leading journals1
- BMJ (Clinical research ed.)1
Leading researchers5
- A'Court C1
- Buxton M1
- Greenhalgh T1
- Husain L1
- Knight M1
Affiliations (unnormalised)2
- University of Oxford1
- West Hertfordshire Hospitals NHS Trust1
Reference
Authoritative identity, definition & identifiers.
Persistent detrimental effects from treatment for a condition. Included are effects from surgery such as POSTOPERATIVE COMPLICATIONS, and from DRUG THERAPY, such as CHEMICALLY INDUCED DISORDERS, or other THERAPEUTICS. Failure to attain a desired outcome from treatment for the condition is not considered an adverse effect.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.